Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen

Immunity

Volumn 4, Issue 3, 1996, Pages 251-262

  Ahearn, Joseph M ^b   Fischer, Michael B ^a   Croix, Denise ^b   Goerg, Siegfried ^a   Ma, Minghe ^a   Xia, Junrong ^a   Zhou, Xioning ^a   Howard, Robert G ^c   Rothstein, Thomas L ^c   Carroll, Michael C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; COMPLEMENT RECEPTOR; THYMUS DEPENDENT ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; GERMINAL CENTER; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL;

EID: 15844412034     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80433-1     Document Type: Article

References (62)

1. Ahearn, J.M., and Fearon, D.T. (1989). Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46, 183-219.
2. Bitter-Suermann, D., and Burger, R. (1989). C3 Deficiencies. Curr. Top. Microbiol. Immunol. 153, 223-233.
3. Boettger, E.C., Metzger, S., Bitter-Suermann, D., Stevenson, G., Kleindienst, S., and Burger, R. (1986). Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur. J. Immunol. 16, 1231-1235.
4. Bradbury, L.E., Kansas, G.S., Levy, S., Evans, R.L., and Tedder, T. F. (1992). The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841-2850.
5. Carroll, M.C., Alicot, E.M., Katzman, P.J., Klickstein, L.B., Smith, J.A., and Fearon, D.T. (1988). Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1. J. Exp. Med. 167, 1271-1280.
6. Carter, R.H., and Fearon, DT. (1992). CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107.
7. Carter, R.H., Spycher, M.O., Ng, Y.C., Hoffman, R., and Fearon, D.T. (1988). Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141, 457-463.
8. Carter, R.H., Tuveson, D.A., Park, D.J., Rhee, S.G., and Fearon, D.T. (1991). The CD19 complex of B lymphocytes: activation of phospholipase C by a protein tyrosine-kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147, 3663-3671.
9. Castigli, E., Alt, F.W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A.K., and Geha, R.S. (1994). CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91, 12135-12139.
10. Croix, D., Ahearn, J.M., Rosengard, A.M., Han, S., Kelsoe, G., Ma, M., and Carroll, M.C. (1996). Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183, in press.
11. Engel, P., Zhou, L.J., Ord, D.C., Sata, S., Koller, B., and Tedder, T.F. (1995). Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3, 39-50.
12. Fearon, D.T., and Carter, R.H. (1995). The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13, 127-149.
13. Finco, O., Li, S., Cuccia, M., Rosen, F.S., and Carroll, M.C. (1992). Structural differences between the two human complement C4 isotypes affects the humoral immune response. J. Exp. Med. 175, 537-543.
14. Fingeroth, J.D., Benedict, M.A., Levy, D.M., and Strominger, J.L. (1989). Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. USA 86, 242.
15. Foy, T.M., Laman, J.D., Ledbetter, J.A., Aruffo, A., Claassen, E., and Noelle, R.J. (1994). gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180, 157-163.
16. Gustavsson, S., Kinoshita, T., and Heyman, B. (1995). Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154, 6524-6528.
17. Han, S., Hathcock, K., Zheng, B., Kepler, T.B., Hodes, R., and Kelsoe, G. (1995). Cellular interactions in germinal centers: roles of CD40 ligand and B7-2 in establishing germinal centers. J. Immunol. 155, 556-567.
18. Hebell, T., Ahearn, J.M., and Fearon, D.T. (1991). Supression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102-105.
19. Herzenberg, L.A., Stall, A.M., Lalor, P.A., Sidman, C., Moore, W.A., Parks, D.R., and Herzenberg, L.A. (1986). The Iy-1 B cell lineage. Immunol. Rev. 93, 81-102.
20. Heyman, B., Pilstrom, L., and Shulman, M.J. (1988). Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 167, 1999-2004.
21. Heyman, B., Wiersma, E.J., and Kinoshita, T. (1990). In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172, 665-668.
22. Humphrey, J.H., Grennan, D., and Sundaram, V. (1984). The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur. J. Immunol. 14, 859-864.
23. Imazeki, N., Senoo, A., and Fuse, Y. (1992). Is the follicular dendritic cell a primary stationary cell? Immunology 76, 508-510.
24. Jackson, C.G., Ochs, H.D., and Wedgewood, R.J. (1979). Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N. Engl. J. Med. 300, 1124-1129.
25. Kalli, K.R., and Fearon, D.T. (1994). Binding of C3b and C4b by the CR1-like site in murine CR1. J. Immunol. 152, 2899-2903.
26. Kansas, G.S., and Tedder, T.F. (1991). Transmembrane signals generated through MHC class II, CD19, CD20, CD39 and CD40 antigens induce LFA-1 dependent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147, 4094-4102.
27. Kantor, A.B. (1991). A new nomenclature for B cells, Immunol. Today 12, 338-339.
28. Kelsoe, G. (1995). The germinal center reaction, Immunol. Today 16, 324-326.
29. Kerner, J.D., Appleby, M.W., Mohr, R.N., Chien, S., Rawlings, D.J., Maliszewski, C.R., Witte, O.N., and Perlmutter, R.M. (1995). Impaired expansion of mouse B cell progenitors lack Btk. Immunity 3, 301-312.
30. Khan, W.N., Alt, F.W., Gerstein, R.M., Malynn, B.A., Larsson, I., Rathbun, G., Davidson, L., Muller, S., Kantor, A.B., Herzenberg, L.A., Rosen, F.S., and Siederas, P. (1995). Defective B cell development and function In Btk-deficient mice. Immunity 3, 283-299.
31. Kinoshita, T., Lavoie, S., and Nussenzweig, V. (1985). Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor 1 (CR1). J. Immunol. 134, 2564-2570.
32. Kinoshita, T., Takeda, J., Hong, K., Kozono, H., Sakai, H., and Inoue, K. (1988). Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140, 3066-3073.
33. Klaus, G.G.B., Humphrey, J.H., Kunkl, A., and Dongworth, D.W. (1980). The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory, Immunol. Rev. 53, 3-59.
34. Koller, B.H., and Smithies, O. (1992). Altering genes in animals by gene targeting. Annu. Rev. Immunol. 10, 705-730.
35. Kosco-Vilbois, M.H., Gray, D., Scheidegger, D., and Julius, M. (1993). Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules. J. Exp. Med. 178, 2055-2066.
36. Kurtz, C.B., O'Toole, E., Christensen, S.M., and Weis, J.H. (1990). The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144, 3581-3591.
37. Law, S.K., Lichtenberg, N.A., and Levine, R.P. (1980). Covalent binding and hemolytic activity of complement proteins. Proc. Natl. Acad. Sci. USA 77, 7194-7198.
38. Liu, Y., and Janeway, C.A. (1992). Cells that present both specific ligand and costimulatory activity the most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA 89, 3845-3849.
39. MacLennan, I.C.M. (1994). Germinal centers. Annu. Rev. Immunol. 12, 117-139.
40. Matsumoto, A.K., Kopicky-Bird, J., Carter, R.H., Tuveson, D.A., Tedder, T.F., and Fearon, D.T. (1991). Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J. Exp. Med. 173, 55-64.
41. Molina, H., Kinoshita, T., Inoue, K., Carel, J.C., and Holers, V.M. (1990). A molecular and immunochemical characterization of mouse CR2. J. Immunol. 145, 2974-2983.
42. Molina, H., Kinoshita, T., Webster, C.B., and Holers, V.M. (1994). Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153, 789-795.
43. Muller-Eberhard, H.J. (1988). Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321-347.
44. O'Neil, K.M., Ochs, H.D., Heller, S.R., Cork, L.C., Morris, J.M., and Winkelstein, J.A. (1988). Role of C3 in humoral immunity: defective antibody production in CS-deficient dogs. J. Immunol. 140, 1939-1945.
45. Ochs, H.D., Wedgwood, R.J., Frank, M.M., Heller, S.R., and Hosea, S.W. (1983). The role of complement In the induction of antibody responses. Clin. Exp. Immunol. 53, 208-216.
46. Papamichail, M., Gutierrez, C., Embling, P., Johnson, P., Holborow, E.J., and Pepys, M.B. (1975). Complement dependence of localization of aggregated IgG in germinal centers. Scand. J. Immunol. 4, 343-347.
47. Pepys, M.B. (1972). Role of complement in induction of the allergic response. Nature New Biol. 237, 157-159.
48. Pramoonjago, P., Takeda, J., Kim, Y.U., Inoue, K., and Kinoshita, T. (1993). Ligand specificities of mouse complement receptors types 1 (CR1) and 2 (CR2) purified from spleen cells. Int. Immunol. 5, 337-343.
49. Ramírez-Solls, R., Rivera-Perez, J., Wallace, J.D., Wims, M., Zhengh, H., and Bradley, A. (1992). Genomic DNA microextraction: a method to screen numerous samples. Anal. Biocnem. 201, 331-335.
50. Rey-Campos, J.P., Rubinstein, P., and Cordoba, R.D. (1988). A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF and C4bp. J. Exp. Med. 167, 664-669.
51. Rickert, R.C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent B cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355.
52. Rose, M.L., Birbeck, B.R., Wallis, V.J., Forrester, J.A., and Davies, A.J.S. (1980). Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature 284, 364-366.
53. Southern, E.M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
54. Szakal, A.K., Kosco, M.H., and Tew, J.G. (1989). Microanatomy of lymphoid tissue during humoral immune responses: structure and function relationships. Annu. Rev. Immunol. 7, 91-109.
55. Tack, B.F., Harrison, R.A., Janatova, J., Thomas, M.L., and Prahl, J.W. (1980). Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl. Acad. Sci. USA 77, 5764-5768.
56. Tarakhovsky, A., Turner, M., Schaal, S., Mee, P.J., Duddy, L.P., Rajewsky, K., and Tybulewicz, V.L.J. (1995). Defective antigen receptor mediated proliferation of B and T cells in the absence of vav. Nature 374, 467-470.
57. Tew, J.G., and Mandel, T.E. (1979). Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology 37, 69-76.
58. Tew, J.G., Kosco, M.H., Burton, G.F., and Szakal, A.K. (1990). Follicular dendritic cells as accessory cells, Immunol. Rev. 117, 185-211.
59. Tuveson, D.A., Carter, R.H., Soltoff, S.P., and Fearon, D.T. (1993). CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260, 986-989.
60. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1154.
61. Wessels, M.R., Butko, P., Ma, M., Warren, H.B., Lage, A., and Carroll, M.C. (1995). Studies of group B steptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92, 11490-11494.
62. Zhang, R., Alt, F.W., Davidson, L., Orkin, S.H., and Swat, W. (1995). Defective signaling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374, 470-473.